返回
Nykode Therapeutics ASA (VACBF) 收益
VACBF 股價走勢圖
VACBF 收益
Nykode Therapeutics ASA
$0.38
0%
$0
收盤價：Mar 24, 16:00:00 GMT-4
$0.38
0%
$0
盤後：Mar 24, 20:00:00 GMT-4
關鍵數據
前收市價
$0.38
開盤價
$0.31
當日範圍
$0.31 - $0.38
52週區間
$0.1557 - $0.38
交易量
10.0K
平均成交量
166
股息收益率
--
每股盈餘 (TTM)
-0.03
市值
$124.0M
什麼是 NYKODE THERAPEUTICS ASA？
Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. The company is headquartered in Oslo, Oslo and currently employs 59 full-time employees. The company went IPO on 2020-01-27. Nykode uses its vaccine technology platform to generate therapeutics in disease indications with unmet medical need. The firm develops next generation vaccines for clinical use, based on a deep understanding of immunological principles. Nykode Therapeutics’ main product candidates are VB10.16 and VB10.NEO. VB10.16 is a therapeutic cancer vaccine against HPV16-related cancers. VB10. NEO is a therapeutic cancer neoantigen vaccine. The firm also has two universal COVID-19 vaccine candidates in development.